STOCK TITAN

Exyn Technologies (EXYN) grants director 23,200 stock options at $1.82

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Exyn Technologies, Inc. reported that director Tewksbury Ted L III received a grant of stock options covering 23,200 shares of common stock on August 3, 2026 at an exercise price of $1.82 per share.

The options vest one-third on August 3, 2027 and one-third on each one-year anniversary thereafter, expire on August 3, 2036, and result in direct holdings of 23,200 stock options.

Positive

  • None.

Negative

  • None.
Insider Tewksbury Ted L III
Role Director
Type Security Shares Price Value
Grant/Award Stock Option F1 23,200 $0.00 $0.00
Holdings After Transaction: Stock Option — 23,200 shares (Direct)
Footnotes (1)
  1. F1. On August 3, 2026 (the "Grant Date"), the Reporting Person was granted stock options to purchase 23,200 shares of the Issuer's common stock. These options vest in accordance with the following schedule: one-third of the shares on August 3, 2027 and one-third on each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Stock options granted 23,200 shares Stock option grant to director on August 3, 2026
Exercise price 1.8200 per share Exercise price of granted stock options
Underlying common shares 23,200 shares Shares of common stock underlying the stock options
Option expiration date 2036-08-03 Expiration date of the granted stock options
Post-grant option holdings 23,200 options Total stock options held directly after the transaction
stock options financial
"was granted stock options to purchase 23,200 shares of the Issuer's common stock"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
exercise price financial
"stock options to purchase 23,200 shares of the Issuer's common stock"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"These options vest in accordance with the following schedule: one-third of the shares"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date":"2036-08-03" for the stock option grant"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
service provider financial
"subject to the Reporting Person continuing as a service provider through each such date"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Exyn Technologies (EXYN) report in this filing?

Exyn Technologies (EXYN) reported that director Tewksbury Ted L III received a grant of stock options covering 23,200 shares of common stock on August 3, 2026 at an exercise price of $1.82 per share.

How many Exyn Technologies (EXYN) shares are covered by the new stock options?

The new stock option grant covers 23,200 shares of Exyn Technologies common stock. These options give the director the right to purchase that number of shares, subject to the vesting schedule and the $1.82 per share exercise price.

What is the exercise price of the Exyn (EXYN) stock options granted to the director?

The stock options granted to the director have an exercise price of $1.82 per share. This is the price at which the director may purchase Exyn common stock for each option that becomes vested and is exercised.

How do the Exyn Technologies (EXYN) stock options vest for the director?

The options vest in three equal installments: one-third on August 3, 2027, and one-third on each one-year anniversary thereafter. Vesting is conditioned on the director continuing as a service provider through each vesting date.

When do the Exyn Technologies (EXYN) stock options granted to the director expire?

The granted stock options expire on August 3, 2036. After that date, any unexercised options will no longer be exercisable, even if they have vested under the stated vesting schedule.

What are the director’s Exyn (EXYN) option holdings after this grant?

Following this grant, the director holds 23,200 stock options directly. These options relate to Exyn Technologies common stock and are subject to the specified vesting schedule and the August 3, 2036 expiration date.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Tewksbury Ted L III

(Last)(First)(Middle)
C/O EXYN TECHNOLOGIES, INC.,
2118 WASHINGTON AVENUE, SUITE 1000

(Street)
PHILADELPHIA PENNSYLVANIA 19146

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Exyn Technologies, Inc. [ EXYN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option$1.8208/03/2026A23,200 (1)08/03/2036Common Stock23,200$023,200D
Explanation of Responses:
1. On August 3, 2026 (the "Grant Date"), the Reporting Person was granted stock options to purchase 23,200 shares of the Issuer's common stock. These options vest in accordance with the following schedule: one-third of the shares on August 3, 2027 and one-third on each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
/s/ Tewksbury Ted L III08/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)